T1	Participants 103 121	healthy volunteers
T2	Participants 447 465	healthy volunteers
T3	Participants 611 676	Healthy male and female volunteers aged 18-75 years were included
T4	Participants 678 903	All volunteers received ASA 81 mg once daily for 5 days prior to the study (pre-screen). Subjects were eligible for inclusion if they had aspirin reactivity units (ARU, as measured by the VerifyNow ASA assay) of <550 on Day 6
T5	Participants 1439 1500	A total of 29 volunteers (19 aged â‰¥50 years; 8 women; 21 men)
